Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study.
Gang WangLe XiaoHongye RenKenneth SimonsenJingdong MaXiangdong XuPing GuoZhiren WangLudong BaiElin H ReinesLene Hammer-HelmichPublished in: Neuropsychiatric disease and treatment (2022)
This study demonstrated the short- and long-term effectiveness and tolerability of vortioxetine for patients with MDD in a real-world setting in China. These findings are consistent with the efficacy and safety profile observed during RCTs.